EP300 and neoplasm: P300-related mechanisms, such as lncTALC-mediated activation of the c-Met/STAT3/p300 axis that may contribute to TMZ resistance, and the SMAD1/p53/p300 complex that regulates acetylation to promote tumor growth and chemoresistance, have been previously described [42, 43].